Single-use Bioreactors Market - Product Launches is the Key Growth Strategy Adopted by Market Players

-
According to research report the single-use bioreactors market is expected to reach USD 2,685.1 Million by 2022 from USD 997.6 Million in 2017, at a CAGR 21.9%. The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and, Thermo Fisher Scientific (US). Increasing adoption of SUBs among small companies and startups and reduced automation complexity are the major factors driving the adoption of single-use bioreactors.
Most companies focus on launching new products to compete in the market. The players also focus on increasing their presence in high-growth markets through agreements, expansions, and acquisitions. Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and Thermo Fisher Scientific (US) focus on product launches and enhancements to strengthen their position in the market.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=49113750
Sartorius Stedim Biotech’s leading position in the single-use bioreactors market can be attributed to its strong product portfolio and wide geographic presence (spanning the Americas, EMEA, and APAC). The company focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and acquisitions. In 2016, the company launched ambr 250, a benchtop mini bioreactor system for parallel fermentation and cell culture. In 2014, the company acquired a majority stake in AllPure Technologies (US). Through this acquisition, the company strengthened its market share in the single-use bioprocessing products market.
Merck Millipore is among the leading players in the single-use bioreactors market. The company offers a strong product portfolio of single-use bioreactor systems and single-use connectors. In order to strengthen its presence and generate a large market share, the company is adopting strategies such as product launches and acquisitions. In 2016, Merck Millipore launched the Mobius 1000L single-use bioreactor. In 2015, Merck acquired Sigma-Aldrich Corporation (US), a life sciences and high-technology company. This acquisition helped Merck to enhance its product portfolio and strengthen its customer base.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750
Some other leading players in the global single-use bioreactors market are Parkin Hannifin (US), Applikon Biotechnology (Netherlands), Eppendorf (Germany), Cesco Bioengineering (Taiwan), and Cellexus (UK). These companies focus significantly on investing in R&D activities to add innovative technologies and products to their portfolio. With a strong portfolio of single-use bioreactor products and ceaseless efforts to develop innovative products, these companies are likely to maintain their strong position in the market in the coming years.

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more